These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents. Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines. Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698 [TBL] [Abstract][Full Text] [Related]
4. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents. Singh FV; Vatsyayan R; Roy U; Goel A Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity. Narender T; Khaliq T; Shweta ; Nishi ; Goyal N; Gupta S Bioorg Med Chem; 2005 Dec; 13(23):6543-50. PubMed ID: 16185885 [TBL] [Abstract][Full Text] [Related]
6. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents. Kumar A; Katiyar SB; Gupta S; Chauhan PM Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents. Agarwal KC; Sharma V; Shakya N; Gupta S Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives. Peyron C; Benhida R; Bories C; Loiseau PM Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines. Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities. Bazin MA; Loiseau PM; Bories C; Letourneux Y; Rault S; El Kihel L Eur J Med Chem; 2006 Oct; 41(10):1109-16. PubMed ID: 16949702 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani. Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents. Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293 [TBL] [Abstract][Full Text] [Related]
14. In pursuit of natural product leads: synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4-carboxylic acid (A-33853) and its analogues: discovery of N-(2-benzoxazol-2-ylphenyl)benzamides as novel antileishmanial chemotypes. Tipparaju SK; Joyasawal S; Pieroni M; Kaiser M; Brun R; Kozikowski AP J Med Chem; 2008 Dec; 51(23):7344-7. PubMed ID: 18989953 [TBL] [Abstract][Full Text] [Related]
15. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani. Kaur J; Sundar S; Singh N J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355 [TBL] [Abstract][Full Text] [Related]